Bausch Health COS Inc
BHCNASDAQStock · Data from SEC EDGAR 13F · Held by 6 of 87 tracked investors
Bausch Health COS Inc at a glance
An overview of the financial statements, in plain language. Switch to the advanced view for charts.
- Valuation95
- Growth70
- Profitability46
- Quality67
- Debt25
- Stability70
- ✓Revenue grew 8.1% a year over 3 years.
- ✓The stock is cheaper: you pay 1.5 USD for 1 USD of annual earnings.
- ✓The analysts' average target is 19% above the price.
- !The company is loss-making: net profit is negative.
- !Net debt is high: at the current free cash flow it would take 13.2 years to repay.
The score describes the quality and the past of the company based on its statements (the FinBoss model, indicative). A high score is not a buy signal and a low one is not a sell signal. Data source: Yahoo Finance, prices and statements in USD.
Is the stock expensive?
Fairly cheapThe company has no earnings, so the P/E cannot be calculated.
- P/E
- –
- P/S
- 0.2×
- EV/EBITDA
- 5.7×
Is the company growing?
GrowingRevenue over 3 years grew 8.1% a year. Last year 12.7%.
Does it make money?
Loss-makingEarnings results
| Quarter | Reported | EPS | Analyst estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | 29 Jul 2026 | 1.26 | 0.96 | +31.3% |
| Mar 2026 | 29 Apr 2026 | 0.78 | 0.81 | -3.7% |
| Dec 2025 | 18 Feb 2026 | 1.08 | 1.21 | -10.7% |
| Sep 2025 | 29 Oct 2025 | 1.16 | 1.07 | +8.4% |
EPS is earnings per share. The surprise is the difference against the analysts' consensus. Source: Nasdaq, in dollars.
Chart BHC
Insider purchases
last 90 days, SEC Form 4Which investors hold this stock
6JP John Paulson Paulson & Co | 14.02% |
MG Mario Gabelli GAMCO Investors | 0.03% |
RD Ray Dalio Bridgewater Associates | 0.02% |
JS Jim Simons Renaissance Technologies | 0.01% |
SC Steven Cohen Point72 Asset Management | 0.01% |
Ns Norský státní fond Norges Bank | 0% |
Frequently asked questions
How much is Bausch Health COS Inc (BHC) stock?
Bausch Health COS Inc shares trade at $6.31, -0.63% over the last trading day. The price is delayed.
What is the market cap of Bausch Health COS Inc?
The market cap of Bausch Health COS Inc is about $2.4B.
Which big investors hold Bausch Health COS Inc?
According to the latest 13F filings, 6 of 87 tracked investors hold Bausch Health COS Inc, for example John Paulson, Mario Gabelli, Ray Dalio.
When will Bausch Health COS Inc report its next results?
The next earnings report of Bausch Health COS Inc is expected on 28 Oct 2026.
Source: SEC EDGAR 13F-HR (quarterly filings). The data is indicative and is not investment advice.